Obstructive Sleep Apnea (OSA) Obesity is the most significant modifiable risk factor for OSA, a condition characterized by recurrent episodes of upper airway collapse during sleep, leading to intermittent hypoxia, sleep fragmentation, and increased cardiovascular risk
The test identifies genetic variants in your GLP-1 receptor (rs6923761), GIP receptor (rs1800437), and appetite-regulation genes like MC4R (rs17782313) that influence your medication responsiveness and plateau risk
Deriving bone marrow macrophages To obtain bone marrow, mice were euthanized, and femurs, tibias, and fibulas were excised
T., Go, V
Regulatory alignment: If the FDA eventually considers addiction indications for GLP-1s, clinical documentation, evidence reporting, and reimbursement models will change substantially